Ethics and the Business of Biomedicine

Ethics and the Business of Biomedicine

by Denis G. Arnold
     
 

ISBN-10: 0521764319

ISBN-13: 9780521764315

Pub. Date: 07/06/2009

Publisher: Cambridge University Press

During the last thirty years we have witnessed sweeping changes in health care worldwide, including new and expensive biomedical technologies, an increasingly powerful and influential pharmaceutical industry, steadily increasing health care costs in industrialized nations, and new threats to medical professionalism. The essays collected in this book concern costs

…  See more details below

Overview

During the last thirty years we have witnessed sweeping changes in health care worldwide, including new and expensive biomedical technologies, an increasingly powerful and influential pharmaceutical industry, steadily increasing health care costs in industrialized nations, and new threats to medical professionalism. The essays collected in this book concern costs and profits in relation to just health care, the often controversial practices of pharmaceutical companies, and corruption in the professional practice of medicine. Leading experts discuss justice in relation to business-friendly strategies in the delivery of health care, access to life-saving drugs, the ethics of pharmaceutical company marketing practices, exploitation in drug trials, and undue industry influence over medicine. They offer guidance regarding the ethical delivery of health care products and services by profit-seeking organizations operating in a global marketplace, and recommend pragmatic solutions to enhance organizational integrity and curb medical corruption in the interest of patient welfare.

Read More

Product Details

ISBN-13:
9780521764315
Publisher:
Cambridge University Press
Publication date:
07/06/2009
Pages:
302
Product dimensions:
6.10(w) x 9.00(h) x 0.80(d)

Table of Contents

List of figures vii

List of contributors viii

Acknowledgements x

Introduction 1

1 Medicine and the market Daniel Callahan 20

2 Broken promises: do business-friendly strategies frustrate just healthcare? Norman Daniels 35

3 Are patents an efficient and internationally fair means of funding research & development for new medicines? Paul T. Menzel 62

4 The exploitation of the economically disadvantaged in pharmaceutical research Tom L. Beauchamp 83

5 The dangers of detailing: how pharmaceutical marketing threatens healthcare Jason E. Hubbard 103

6 The ethics of direct-to-consumer pharmaceutical advertising Denis G. Arnold 131

7 Industry-funded bioethics and the limits of disclosure Carl Elliott 150

8 Two cheers for the pharmaceutical industry Richard T. De George 169

9 The third face of medicine: ethics, business and challenges to professionalism Mary Rorty Patricia Werhane Ann Mills 198

10 Theoretical foundations for organizational ethics: developing norms for a new kind of healthcare George Khushf 220

11 A crisis in medical professionalism: time for Flexner II Daniel Wikler 249

Bibliography 260

Index 283

Read More

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >